Comparison of osteogenic differentiation induced by siNoggin and pBMP-2 delivered by lipopolysaccharide-amine nanopolymersomes and underlying molecular mechanisms

References

• Kowalczewski CJ, Saul JM. Biomaterials for the delivery of growth factors and other therapeutic agents in tissue engineering approaches to bone regeneration. Front Pharmacol. 2018;9:513. doi:10.3389/fphar.2018.0051329896102
   PubMed Web of Science ®Google Scholar
• Hak DJ, Fitzpatrick D, Bishop JA, et al. Delayed union and nonunions: epidemiology, clinical issues, and financial aspects. Injury. 2014;45(Suppl 2):S3–S7. doi:10.1016/j.injury.2014.04.002
   PubMed Web of Science ®Google Scholar
• Haumer A, Bourgine PE, Occhetta P, et al. Delivery of cellular factors to regulate bone healing. Adv Drug Deliv Rev. 2018;129:285–294. doi:10.1016/j.addr.2018.01.01029357301
   PubMedGoogle Scholar
• Bai X, Gao M, Syed S, et al. Bioactive hydrogels for bone regeneration. Bioact Mater. 2018;3(4):401–417. doi:10.1016/j.bioactmat.2018.05.00630003179
   PubMed Web of Science ®Google Scholar
• Hasan A, Byambaa B, Morshed M, et al. Advances in osteobiologic materials for bone substitutes. J Tissue Eng Regen Med. 2018;12(6):1448–1468. doi:10.1002/term.267729701908
   PubMed Web of Science ®Google Scholar
• Inada T, Tamura A, Terauchi M, Yamaguchi S, Yui N. A silencing-mediated enhancement of osteogenic differentiation by supramolecular ternary siRNA polyplexes comprising biocleavable cationic polyrotaxanes and anionic fusogenic peptides. Biomater Sci. 2018;6(2):440–450. doi:10.1039/c8bm00675j29355872
   PubMedGoogle Scholar
• Liu H, Li D, Zhang Y, Li M. Inflammation, mesenchymal stem cells and bone regeneration. Histochem Cell Biol. 2018;149(4):393–404. doi:10.1007/s00418-018-1643-329435765
   PubMedGoogle Scholar
• Nguyen MK, Jeon O, Dang PN, et al. RNA interfering molecule delivery from in situ forming biodegradable hydrogels for enhancement of bone formation in rat calvarial bone defects. Acta Biomater. 2018;75:105–114. doi:10.1016/j.actbio.2018.06.00729885529
   PubMedGoogle Scholar
• Tatiparti K, Sau S, Kashaw SK, Iyer AK. siRNA delivery strategies: a comprehensive review of recent developments. Nanomaterials (Basel). 2017;7(4). doi:10.3390/nano7120458
   PubMedGoogle Scholar
• Krause C, Guzman A, Knaus P. Noggin. Int J Biochem Cell Biol. 2011;43(4):478–481. doi:10.1016/j.biocel.2010.11.01521256973
   PubMed Web of Science ®Google Scholar
• Pensak MJ, Lieberman JR. Gene therapy for bone regeneration. Curr Pharm Des. 2013;19(19):3466–3473. doi:10.2174/138161281131919001223432674
   PubMedGoogle Scholar
• Zhang X, Guo J, Zhou Y, Wu G. The roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cells. Tissue Eng Part B Rev. 2014;20(1):84–92. doi:10.1089/ten.teb.2013.020423758605
   PubMedGoogle Scholar
• Wagner DO, Sieber C, Bhushan R, et al. BMPs: from bone to body morphogenetic proteins. Sci Signal. 2010;3(107):mr1.20124549
   PubMed Web of Science ®Google Scholar
• Molina CS, Stinner DJ, Obremskey WT. Treatment of traumatic segmental long-bone defects: a critical analysis review. JBJS Rev. 2014;2(4). doi:10.2106/JBJS.RVW.M.00062
   PubMedGoogle Scholar
• Nguyen MK, Jeon O, Krebs MD, Schapira D, Alsberg E. Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation. Biomaterials. 2014;35(24):6278–6286. doi:10.1016/j.biomaterials.2014.01.02624831973
   PubMedGoogle Scholar
• Carreira AC, Zambuzzi WF, Rossi MC, et al. Bone morphogenetic proteins: promising molecules for bone healing, bioengineering, and regenerative medicine. Vitam Horm. 2015;99:293–322.26279381
   PubMed Web of Science ®Google Scholar
• Cui ZK, Fan J, Kim S, et al. Delivery of siRNA via cationic Sterosomes to enhance osteogenic differentiation of mesenchymal stem cells. J Control Release. 2015;217:42–52. doi:10.1016/j.jconrel.2015.08.03126302903
   PubMed Web of Science ®Google Scholar
• Orciani M, Fini M, Di Primio R, Mattioli-Belmonte M. Biofabrication and bone tissue regeneration: cell source, approaches, and challenges. Front Bioeng Biotechnol. 2017;5:17. doi:10.3389/fbioe.2017.0001728386538
   PubMedGoogle Scholar
• Ramasubramanian A, Shiigi S, Lee GK, Yang F. Non-viral delivery of inductive and suppressive genes to adipose-derived stem cells for osteogenic differentiation. Pharm Res. 2011;28(6):1328–1337. doi:10.1007/s11095-011-0406-921424160
   PubMedGoogle Scholar
• Zhou Z, Liu X, Zhu D, et al. Nonviral cancer gene therapy: delivery cascade and vector nanoproperty integration. Adv Drug Deliv Rev. 2017;115:115–154. doi:10.1016/j.addr.2017.07.02128778715
   PubMed Web of Science ®Google Scholar
• Leong J, Teo JY, Aakalu VK, Yang YY, Kong H. Engineering polymersomes for diagnostics and therapy. Adv Healthc Mater. 2018;7(8):e1701276. doi:10.1002/adhm.20170127629334183
   PubMedGoogle Scholar
• Chidanguro T, Ghimire E, Liu CH, Simon YC. Polymersomes: breaking the glass ceiling? Small. 2018;14(46):e1802734. doi:10.1002/smll.v14.4630369045
   PubMedGoogle Scholar
• Shi Y, Jiang Y, Cao J, et al. Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes. J Control Release. 2018;292:163–171. doi:10.1016/j.jconrel.2018.10.03430408555
   PubMedGoogle Scholar
• Zou Y, Zheng M, Yang W, et al. Virus-mimicking chimaeric polymersomes boost targeted cancer siRNA therapy in vivo. Adv Mater. 2017;29(42). doi:10.1002/adma.201700681
   Web of Science ®Google Scholar
• Ge X, Zhang Q, Cai Y, et al. PEG-PCL-DEX polymersome-protamine vector as an efficient gene delivery system via PEG-guided self-assembly. Nanomedicine (Lond). 2014;9(8):1193–1207. doi:10.2217/nnm.13.8324294982
   PubMedGoogle Scholar
• Huang Z, Teng W, Liu L, et al. Efficient cytosolic delivery mediated by polymersomes facilely prepared from a degradable, amphiphilic, and amphoteric copolymer. Nanotechnology. 2013;24(26):265104. doi:10.1088/0957-4484/24/26/26510423735836
   PubMedGoogle Scholar
• Guan Y, Wang Q, Cheng Y, Teng W, Huang H. Study on gene transfection in bone marrow mesenchymal stem cells mediated by plasmid of bone morphogenetic protein 2 loaded lipopolysaccharide-amine nanopolymersomes. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2014;28(10):1292–1297.25591310
   PubMedGoogle Scholar
• Teng W, Huang Z, Chen Y, et al. pVEGF-loaded lipopolysaccharide-amine nanopolymersomes for therapeutic angiogenesis. Nanotechnology. 2014;25(6):065702. doi:10.1088/0957-4484/25/6/06570224434195
   PubMedGoogle Scholar
• Wang Q, Chen Y, Wang L, et al. Stability and toxicity of empty or gene-loaded lipopolysaccharide-amine nanopolymersomes. Int J Nanomedicine. 2015;10:597–608. doi:10.2147/IJN.S7415625609964
   PubMedGoogle Scholar
• Fan J, Im CS, Guo M, et al. Enhanced osteogenesis of adipose-derived stem cells by regulating bone morphogenetic protein signaling antagonists and agonists. Stem Cells Transl Med. 2016;5(4):539–551. doi:10.5966/sctm.2015-024926956209
   PubMedGoogle Scholar
• Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Mineral Res. 1992;7(6):683–692. doi:10.1002/jbmr.5650070613
   PubMed Web of Science ®Google Scholar
• Groppe J, Greenwald J, Wiater E, et al. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature. 2002;420(6916):636–642. doi:10.1038/nature0113112478285
   PubMed Web of Science ®Google Scholar
• Kaidanovich-Beilin O, Woodgett JR. GSK-3: functional insights from cell biology and animal models. Front Mol Neurosci. 2011;4:40. doi:10.3389/fnmol.2011.0004022110425
   PubMed Web of Science ®Google Scholar
• Lin FX, Zheng GZ, Chang B, et al. Connexin 43 modulates osteogenic differentiation of bone marrow stromal cells through GSK-3beta/beta-catenin signaling pathways. Cell Physiol Biochem. 2018;47(1):161–175. doi:10.1159/00049162029763908
   PubMedGoogle Scholar
• Shapiro G, Lieber R, Gazit D, Pelled G. Recent advances and future of gene therapy for bone regeneration. Curr Osteoporos Rep. 2018;16:504–511. doi:10.1007/s11914-018-0459-329909597
   PubMedGoogle Scholar
• Casati L, Pagani F, Fibiani M, Lo Scalzo R, Sibilia V. Potential of delphinidin-3-rutinoside extracted from Solanum melongena L. as promoter of osteoblastic MC3T3-E1 function and antagonist of oxidative damage. Eur J Nutr. 2018. doi:10.1007/s00394-018-1618-0
   PubMed Web of Science ®Google Scholar
• Qing T, Mahmood M, Zheng Y, et al. A genomic characterization of the influence of silver nanoparticles on bone differentiation in MC3T3-E1 cells. J Appl Toxicol. 2018;38(2):172–179. doi:10.1002/jat.352828975650
   PubMedGoogle Scholar
• Fan J, Park H, Tan S, Lee M. Enhanced osteogenesis of adipose derived stem cells with Noggin suppression and delivery of BMP-2. PLoS One. 2013;8(8):e72474. doi:10.1371/journal.pone.007247423977305
   PubMedGoogle Scholar
• Fan J, Park H, Lee MK, et al. Adipose-derived stem cells and BMP-2 delivery in chitosan-based 3D constructs to enhance bone regeneration in a rat mandibular defect model. Tissue Eng Part A. 2014;20(15–16):2169–2179. doi:10.1089/ten.tea.2013.052324524819
   PubMed Web of Science ®Google Scholar
• Levi B, Nelson ER, Hyun JS, et al. Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor. Plast Reconstr Surg. 2012;129(1):53–66. doi:10.1097/PRS.0b013e3182361ff521915082
   PubMedGoogle Scholar